Cargando…
Effect of myocardial dysfunction in cardiac morbidity and all cause mortality in childhood cancer subjects treated with anthracycline therapy
BACKGROUND: Subacute cardiotoxicity, consisting of acute myocyte damage and associated left ventricular dysfunction, occurs early during anthracycline therapy. We investigated the impact of myocardial dysfunction, defined herein by a shortening fraction (SF) < 29 % at any time during or after ant...
Autores principales: | Toro-Salazar, Olga H., Gillan, Eileen, Ferranti, Joanna, Orsey, Andrea, Rubin, Karen, Upadhyay, Shailendra, Mazur, Wojciech, Hor, Kan N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837140/ https://www.ncbi.nlm.nih.gov/pubmed/33530141 http://dx.doi.org/10.1186/s40959-015-0005-8 |
Ejemplares similares
-
Cardiac magnetic resonance characteristics of acute anthracycline-induced cardiotoxicity
por: Toro-Salazar, Olga H, et al.
Publicado: (2016) -
Defining late onset occult asymptomatic cardiotoxicity in childhood cancer survivors exposed to anthracycline therapy: a cardiac magnetic resonance imaging study
por: Toro-Salazar, Olga H, et al.
Publicado: (2013) -
Use of integrated imaging and serum biomarker profiles to identify subclinical dysfunction in pediatric cancer patients treated with anthracyclines
por: Toro-Salazar, Olga H., et al.
Publicado: (2018) -
Serial assessment of myocardial T2 in Duchenne muscular dystrophy
por: Wansapura, Janaka, et al.
Publicado: (2011) -
Pregnancy and Cardiomyopathy After Anthracyclines in Childhood
por: Thompson, Kara Annette
Publicado: (2018)